https://www.selleckchem.com/pr....oducts/atezolizumab.
Microsatellite insertions and deletions generated antigenic mutant proteins shared among patients.MHC-I and MHC-II regulators in lymphomas, some of which had subtype or tumor specificity, were identified.KRAS/LKB1-comutant NSCLC had high flux through and dependence on the hexosamine biosynthesis pathway.Researchers launched the American Society of Hematology Research Collaborative COVID-19 Registry for Hematology in April to gather real-time data on patients with hematologic malignancies who develop COVID-19. Now, an analysis of th
Like
Comment
Share
